T. David Pallin - Concepedia

Author

T. David Pallin

Charles River Laboratories (United Kingdom)ORCID

Also Known As

David Pallin, T David Pallin, T. D. PALLIN, T. D. Pallin, T. David Pallin, T.D. Pallin, Thomas D. Pallin, Thomas David Pallin

Publications

453

Citations

H-Index

Concepts

All Affiliations

Charles River Laboratories (United Kingdom)University of Siena The Queen's Medical Research Institute University of Edinburgh

About

T. David Pallin is an author at Charles River Laboratories (United Kingdom) specializing in biochemistry, organic chemistry, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Biochemistry	5	5	233
2	Medicine	4	4	236
3	Natural Sciences	4	4	194
4	Engineering	2	2	38
5	Health Sciences	2	2	92

T. David Pallin

Publications

452

Citations

H-Index

Page 1

	Year	Citations
Cyclic Peptides from Linear Unprotected Peptide Precursors through Thiazolidine Formation Paolo Botti, T. David Pallin, James P. Tam Journal of the American Chemical Society Bioorganic ChemistryPeptide EngineeringMacrocyclization MethodsOrganic ChemistryPeptide Science	1996	117
SAR Studies Leading to the Identification of a Novel Series of Metallo-β-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model Simon Leiris, Alicia Coelho, Jérôme Castandet, ACS Infectious Diseases Metallo-β-lactamase InhibitorsPharmacotherapyAntimicrobial ChemotherapyAntibiotic ResistanceBacterial Pathogens	2018	53
Selection and early clinical evaluation of the brain‐penetrant 11β‐hydroxysteroid dehydrogenase type 1 (11β‐HSD1) inhibitor UE2343 (Xanamem™) Scott P. Webster, Andrew McBride, Margaret Binnie, British Journal of Pharmacology	2016	52
11β-Hydroxysteroid dehydrogenase type 1 inhibitors as therapeutic agents Scott P. Webster, T. David Pallin Expert Opinion on Therapeutic Patents Metabolic DisorderPharmacotherapyGlucocorticoidCaloric RestrictionTherapeutic Agents	2007	39
Discovery of <b>ANT3310</b>, a Novel Broad-Spectrum Serine β-Lactamase Inhibitor of the Diazabicyclooctane Class, Which Strongly Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacterales and <i>Acinetobacter baumannii</i> David T. Davies, Simon Leiris, Magdalena Zalacaín, Journal of Medicinal Chemistry	2020	34
Chemical Optimization of Selective <i>Pseudomonas aeruginosa</i> LasB Elastase Inhibitors and Their Impact on LasB-Mediated Activation of IL-1β in Cellular and Animal Infection Models Martin Everett, David T. Davies, Simon Leiris, ACS Infectious Diseases	2023	28
Cyclisation of totally unprotected peptides in aqueous solution by oxime formation T. David Pallin, James P. Tam Journal of the Chemical Society Chemical Communications Bioorganic ChemistryPhysicsBiochemistryUnprotected PeptidesAqueous Solution	1995	27
Tetrahydrocarbazoles are a novel class of potent P-type ATPase inhibitors with antifungal activity Maike Bublitz, Lasse Kjellerup, Karen O’Hanlon Cohrt, PLoS ONE Crystal StructureMolecular BiologyAntimicrobial ChemotherapyChemical BiologyDrug Resistance	2018	27
A new method of forming resin bound thioesters and their use as ‘traceless’ linkers in solid phase synthesis Peter J May, Mark Bradley, T. David Pallin Tetrahedron Letters Materials ScienceResin Bound ThioestersEngineeringOrganic ChemistrySolid Phase Synthesis	2000	24
Modulation of 11β-hydroxysteroid dehydrogenase type 1 activity by 1,5-substituted 1H-tetrazoles Scott P. Webster, Margaret Binnie, Kirsty M.M. McConnell, Bioorganic & Medicinal Chemistry Letters Bioorganic ChemistryAldehyde DehydrogenaseBiochemistryNatural Sciences1,5-Substituted 1H-tetrazoles	2010	23

Page 1